GENFIT Share Price Börse Stuttgart
Stocks
XUP
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.14 EUR | +5.05% |
|
+5.74% | +174.51% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 679M 782M 631M 582M 1.1B 74.67B 1.12B 7.47B 2.92B 37.08B 2.94B 2.87B 125B | P/E 2026 * |
35x | P/E 2027 * | 90.2x |
|---|---|---|---|---|---|
| Enterprise Value | 628M 723M 583M 538M 1.01B 69.05B 1.03B 6.91B 2.7B 34.29B 2.72B 2.66B 115B | EV / Sales 2026 * |
6.27x | EV / Sales 2027 * | 4.94x |
| Free-Float |
86.88% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +5.05% | ||
| 1 week | +5.74% | ||
| Current month | +32.58% | ||
| 1 month | +32.58% | ||
| 3 months | +74.13% | ||
| 6 months | +152.48% | ||
| Current year | +174.51% |
| 1 week | 12.96 |  | 14.04 |
| 1 month | 10.16 | | 14.24 |
| Current year | 5.06 | | 14.24 |
| 1 year | 3.58 | | 14.24 |
| 3 years | 3.3 | | 14.24 |
| 5 years | 2.96 | | 14.24 |
| 10 years | 2.96 | | 21.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 15/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 21/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 26/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 15/06/2017 | |
| Director/Board Member | 54 | 14/09/1999 | |
| Director/Board Member | 58 | 15/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.05% | +5.74% | - | - | 773M | |
| -0.80% | +5.16% | -0.70% | +12.87% | 48.95B | |
| -4.11% | +14.18% | +23.58% | +5.79% | 40.75B | |
| +4.40% | -0.09% | +409.47% | +618.40% | 38.46B | |
| -1.84% | -2.01% | +6.76% | +49.48% | 36.38B | |
| +5.56% | +11.70% | +11.64% | +51.50% | 28.45B | |
| -1.56% | -2.05% | - | - | 16.62B | |
| -1.08% | -4.27% | +32.48% | +129.08% | 16.33B | |
| -7.00% | -2.33% | -8.34% | -33.83% | 13.65B | |
| -0.06% | +3.75% | +3.81% | +9.62% | 13.56B | |
| Average | -0.06% | +6.06% | +59.84% | +105.36% | 28.13B | |
| Weighted average by Cap. | -0.18% | +7.20% | +74.92% | +125.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 100M 115M 93.04M 85.81M 162M 11.01B 165M 1.1B 431M 5.47B 433M 424M 18.39B | 124M 143M 115M 106M 200M 13.63B 204M 1.36B 534M 6.77B 536M 525M 22.77B |
| Net income | 22.88M 26.34M 21.24M 19.59M 36.91M 2.51B 37.58M 252M 98.48M 1.25B 98.91M 96.75M 4.2B | 6.8M 7.83M 6.31M 5.82M 10.97M 747M 11.17M 74.76M 29.27M 371M 29.4M 28.76M 1.25B |
| Net Debt | -51.12M -58.85M -47.47M -43.78M -82.46M -5.62B -83.96M -562M -220M -2.79B -221M -216M -9.38B | -66.17M -76.18M -61.45M -56.67M -107M -7.27B -109M -727M -285M -3.61B -286M -280M -12.15B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/07/26 | €14.00 | +4.01% | 5,322 |
| 29/07/26 | €13.46 | +2.44% | 3,742 |
| 28/07/26 | €13.14 | -2.67% | 10,517 |
| 27/07/26 | €13.50 | +1.35% | 5,700 |
| 24/07/26 | €13.32 | +0.60% | 4,736 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
Select your edition
All financial news and data tailored to specific country editions
